Home/Filings/4/0001018952-05-000052
4//SEC Filing

KOS PHARMACEUTICALS INC 4

Accession 0001018952-05-000052

CIK 0001018952operating

Filed

May 22, 8:00 PM ET

Accepted

May 23, 4:44 PM ET

Size

9.2 KB

Accession

0001018952-05-000052

Insider Transaction Report

Form 4
Period: 2005-05-20
KIRITSY CHRISTOPHER P
Executive VP and CFO
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2005-05-205,00051,500 total
    Exercise: $19.50Exp: 2013-01-22Common Stock (5,000 underlying)
  • Sale

    Common Stock, $.01 Par Value

    2005-05-20$55.00/sh5,000$275,0003,000 total
  • Exercise/Conversion

    Common Stock, $.01 Par Value

    2005-05-20$19.50/sh+5,000$97,5008,000 total
Footnotes (3)
  • [F1]Includes one share jointly owned with spouse.
  • [F2]Includes 2,999 shares of Kos common stock acquired by reporting person in transactions exempt under Section 16 of the Exchange Act under the Kos 401(k) plan and the Employee Stock Purchase Plan.
  • [F3]Part of an original grant of 85,000 options, exercisable in the following amounts on the following exercise dates: 21,250 on January 23, 2004 21,250 on January 23, 2005 21,250 on January 23, 2006 21,250 on January 23, 2007

Issuer

KOS PHARMACEUTICALS INC

CIK 0001018952

Entity typeoperating
IncorporatedFL

Related Parties

1
  • filerCIK 0001018952

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:44 PM ET
Size
9.2 KB